Mildronate effects on oxidant stress in type 2 diabetic patients with diabetic peripheral (sensomotor) neuropathy

Terapevticheskii Arkhiv

Volumn 80, Issue 10, 2008, Pages 27-30

  Statsenko, M E ^a   Poletaeva, L V ^a   Turkina, S V ^a   Apukhtin, A F ^a   Dudchenko, G P ^a  

^a VOLGOGRAD STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

Mildronate; Oxidant stress; Peripheral neuropathy; Treatment; Type 2 diabetes mellitus

Indexed keywords

EID: 57649125431     PISSN: 00403660     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Russian source
2. Baynes J. W., Thorpe S. R. Oxidative stress in diabetes. In: Packer L., ed. Antioxidants in diabetes management. New York: M. Dekker Inc.; 2000. 77-92.
3. UK Prospective Diabetes Study (UKPDS) Group: Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control (UKPDS 37). Diabet. Care 1999; 7: 125-136.
4. Russian source
5. Russian source
6. Russian source
7. Ziegler D., Hanefeld M., Ruhnau K. J. et al. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-lipoic acid in diabetic neuropathy. Diabet. Care 1999; 8: 1296-1301.
8. Russian source
9. Russian source
10. Russian source
11. Young M. J., Boulton A. J. M., Macleod A. F. et al. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia 1993; 36: 150-154.
12. Russian source
13. Russian source
14. Russian source
15. Russian source
16. Russian source
17. Russian source
18. Russian source
19. Russian source
20. Russian source